BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24274664)

  • 1. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia.
    Gierer S; Hofmann-Winkler H; Albuali WH; Bertram S; Al-Rubaish AM; Yousef AA; Al-Nafaie AN; Al-Ali AK; Obeid OE; Alkharsah KR; Pöhlmann S
    Emerg Infect Dis; 2013 Dec; 19(12):2034-6. PubMed ID: 24274664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013.
    Hemida MG; Perera RA; Wang P; Alhammadi MA; Siu LY; Li M; Poon LL; Saif L; Alnaeem A; Peiris M
    Euro Surveill; 2013 Dec; 18(50):20659. PubMed ID: 24342517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012.
    Aburizaiza AS; Mattes FM; Azhar EI; Hassan AM; Memish ZA; Muth D; Meyer B; Lattwein E; Müller MA; Drosten C
    J Infect Dis; 2014 Jan; 209(2):243-6. PubMed ID: 24218504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012.
    Memish ZA; Alsahly A; Masri MA; Heil GL; Anderson BD; Peiris M; Khan SU; Gray GC
    Influenza Other Respir Viruses; 2015 Mar; 9(2):64-7. PubMed ID: 25470665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.
    Hemida MG; Perera RA; Al Jassim RA; Kayali G; Siu LY; Wang P; Chu KW; Perlman S; Ali MA; Alnaeem A; Guan Y; Poon LL; Saif L; Peiris M
    Euro Surveill; 2014 Jun; 19(23):. PubMed ID: 24957744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.
    Müller MA; Meyer B; Corman VM; Al-Masri M; Turkestani A; Ritz D; Sieberg A; Aldabbagh S; Bosch BJ; Lattwein E; Alhakeem RF; Assiri AM; Albarrak AM; Al-Shangiti AM; Al-Tawfiq JA; Wikramaratna P; Alrabeeah AA; Drosten C; Memish ZA
    Lancet Infect Dis; 2015 May; 15(5):559-64. PubMed ID: 25863564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016.
    Degnah AA; Al-Amri SS; Hassan AM; Almasoud AS; Mousa M; Almahboub SA; Alhabbab RY; Mirza AA; Hindawi SI; Alharbi NK; Azhar EI; Hashem AM
    J Infect Public Health; 2020 May; 13(5):697-703. PubMed ID: 32005618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
    Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia, 2016-2018.
    Tolah AM; Al Masaudi SB; El-Kafrawy SA; Mirza AA; Harakeh SM; Hassan AM; Alsaadi MA; Alzahrani AA; Alsaaidi GA; Amor NMS; Alagaili AN; Hashem AM; Azhar EI
    PLoS One; 2020; 15(5):e0232790. PubMed ID: 32453746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia.
    Al-Abdely HM; Midgley CM; Alkhamis AM; Abedi GR; Lu X; Binder AM; Alanazi KH; Tamin A; Banjar WM; Lester S; Abdalla O; Dahl RM; Mohammed M; Trivedi S; Algarni HS; Sakthivel SK; Algwizani A; Bafaqeeh F; Alzahrani A; Alsharef AA; Alhakeem RF; Jokhdar HAA; Ghazal SS; Thornburg NJ; Erdman DD; Assiri AM; Watson JT; Gerber SI
    Emerg Infect Dis; 2019 Apr; 25(4):753-766. PubMed ID: 30882305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.
    Harcourt JL; Rudoler N; Tamin A; Leshem E; Rasis M; Giladi M; Haynes LM
    Zoonoses Public Health; 2018 Sep; 65(6):749-754. PubMed ID: 29855166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) specific antibodies in dromedary camels in Tabuk, Saudi Arabia.
    Harrath R; Abu Duhier FM
    J Med Virol; 2018 Aug; 90(8):1285-1289. PubMed ID: 29663439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya.
    Ommeh S; Zhang W; Zohaib A; Chen J; Zhang H; Hu B; Ge XY; Yang XL; Masika M; Obanda V; Luo Y; Li S; Waruhiu C; Li B; Zhu Y; Ouma D; Odendo V; Wang LF; Anderson DE; Lichoti J; Mungube E; Gakuya F; Zhou P; Ngeiywa KJ; Yan B; Agwanda B; Shi ZL
    Virol Sin; 2018 Dec; 33(6):484-492. PubMed ID: 30570714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013.
    Meyer B; Müller MA; Corman VM; Reusken CB; Ritz D; Godeke GJ; Lattwein E; Kallies S; Siemens A; van Beek J; Drexler JF; Muth D; Bosch BJ; Wernery U; Koopmans MP; Wernery R; Drosten C
    Emerg Infect Dis; 2014 Apr; 20(4):552-9. PubMed ID: 24655412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic Analysis of MERS-CoV in a Camel Abattoir, Saudi Arabia, 2016-2018.
    Hemida MG; Chu DKW; Chor YY; Cheng SMS; Poon LLM; Alnaeem A; Peiris M
    Emerg Infect Dis; 2020 Dec; 26(12):3089-3091. PubMed ID: 33219804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
    Arabi YM; Hajeer AH; Luke T; Raviprakash K; Balkhy H; Johani S; Al-Dawood A; Al-Qahtani S; Al-Omari A; Al-Hameed F; Hayden FG; Fowler R; Bouchama A; Shindo N; Al-Khairy K; Carson G; Taha Y; Sadat M; Alahmadi M
    Emerg Infect Dis; 2016 Sep; 22(9):1554-61. PubMed ID: 27532807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MERS-CoV Antibodies in Humans, Africa, 2013-2014.
    Liljander A; Meyer B; Jores J; Müller MA; Lattwein E; Njeru I; Bett B; Drosten C; Corman VM
    Emerg Infect Dis; 2016 Jun; 22(6):1086-9. PubMed ID: 27071076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.
    Payne DC; Iblan I; Rha B; Alqasrawi S; Haddadin A; Al Nsour M; Alsanouri T; Ali SS; Harcourt J; Miao C; Tamin A; Gerber SI; Haynes LM; Al Abdallat MM
    Emerg Infect Dis; 2016 Oct; 22(10):1824-6. PubMed ID: 27332149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
    Müller MA; Corman VM; Jores J; Meyer B; Younan M; Liljander A; Bosch BJ; Lattwein E; Hilali M; Musa BE; Bornstein S; Drosten C
    Emerg Infect Dis; 2014 Dec; 20(12):2093-5. PubMed ID: 25425139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia.
    Kasem S; Qasim I; Al-Hufofi A; Hashim O; Alkarar A; Abu-Obeida A; Gaafer A; Elfadil A; Zaki A; Al-Romaihi A; Babekr N; El-Harby N; Hussien R; Al-Sahaf A; Al-Doweriej A; Bayoumi F; Poon LLM; Chu DKW; Peiris M; Perera RAPM
    J Infect Public Health; 2018; 11(3):331-338. PubMed ID: 28993171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.